Last reviewed: May 28, 2026
Last updated: May 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Methylene blue benefits center on its redox-active properties and potential mitochondrial support, though clinical evidence remains inconsistent across indications. Early studies suggest possible cognitive and mood-related effects, but robust large-scale trials are limited.
For patients exploring precision wellness strategies, understanding your individual biomarker profile and genetic predispositions can help contextualize whether methylene blue or other supportive agents align with your health goals. PlexusDx supports informed conversations with qualified providers.
How Methylene Blue Works at the Cellular Level
Methylene blue acts as an electron donor and acceptor in the mitochondrial electron transport chain, potentially improving ATP production and reducing oxidative stress. This dual-action mechanism forms the theoretical basis for its proposed benefits in energy metabolism and cellular function.
The compound can cross the blood-brain barrier, which differentiates it from many other antioxidants and explains interest in neurological applications. However, clinical translation of these biochemical properties remains incomplete and requires careful provider interpretation.
Clinical Evidence and Study Quality Across Key Applications
Methylene blue has been examined in cognitive decline, mood disorders, and septic shock, yet study heterogeneity and small sample sizes limit definitive conclusions. Below is a framework comparing available evidence strength across major applications:
| Application |
Evidence Level |
Study Sample Size |
Clinical Consensus |
| Cognitive enhancement (healthy adults) |
Limited, observational |
Mostly <50 participants |
Insufficient for recommendation |
| Alzheimer's disease progression |
Mixed; some small trials |
10–100 participants per trial |
Promising but not standard care |
| Mood and depression support |
Preliminary case reports |
Mostly anecdotal |
Requires larger RCTs |
| Mitochondrial disorders |
Theoretical; rare case reports |
Case-by-case data |
Specialist evaluation essential |
Biomarker and Genetic Context for Methylene Blue Consideration
Individual differences in redox enzyme activity, mitochondrial function markers, and oxidative stress biomarkers may influence how someone responds to methylene blue. Genetic variants in pathways involving cytochrome P450 metabolism and antioxidant defense can shape both efficacy and side-effect risk.
PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and energy-regulatory gene pathways that may help contextualize discussions about supportive compounds. These insights should be interpreted with a qualified provider to determine if methylene blue aligns with your individual biology and health goals.
Safety Profile, Dosing, and Who Should Avoid Methylene Blue
Methylene blue is generally well-tolerated at low doses (0.5–2 mg/kg), but risks include serotonin syndrome when combined with SSRIs, blue discoloration of urine and skin, and rare hemolytic anemia in glucose-6-phosphate dehydrogenase (G6PD) deficiency. Higher doses increase adverse-event likelihood.
Patients with G6PD deficiency, those taking serotonergic medications, pregnant or nursing individuals, and people with significant kidney or liver disease should avoid methylene blue or consult a specialist first. A qualified provider must assess individual contraindications and drug interactions before use.
How PlexusDx Supports a More Personalized Approach
PlexusDx genetic testing may help provide context on your individual predispositions in mitochondrial energy regulation and antioxidant defense pathways. These variants—while not deterministic of methylene blue response—can support a more informed conversation with your provider about whether supportive compounds align with your metabolic profile.
The Precision Peptide Genetic Test reveals predispositions in pathways including FTO (metabolic regulation) and other energy-related gene variants. These insights do not predict exact outcomes with methylene blue but may help your provider understand your baseline redox biology and metabolic capacity.
Understanding your genetic and biomarker context empowers you and your provider to make evidence-based decisions about which supportive agents to prioritize. PlexusDx recommends discussing test results and methylene blue consideration with a qualified healthcare provider to ensure personalized, safe recommendations.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the most established clinical use of methylene blue?
Methylene blue is FDA-approved for methemoglobinemia treatment. Its use for cognitive, mood, or mitochondrial support remains experimental and should only be considered under provider guidance with careful monitoring.
Can methylene blue interact with antidepressants or other common medications?
Yes. Methylene blue combined with SSRIs or SNRIs carries serotonin syndrome risk. It may also interact with other medications. Always disclose all medications to your provider before considering methylene blue.
Does PlexusDx offer methylene blue as a product?
No. PlexusDx specializes in compounded GLP-1 peptides and the Precision Peptide Genetic Test. Methylene blue discussions should occur with your qualified healthcare provider, not through PlexusDx.
What are the most common side effects of methylene blue?
Blue discoloration of urine and skin are most common at standard doses. Nausea, headache, and dizziness occur less frequently. Serious risks include serotonin syndrome and hemolytic anemia in G6PD-deficient individuals.
How does the Precision Peptide Genetic Test relate to methylene blue response?
The test reveals predispositions in metabolic and energy-regulation pathways that may inform your provider's assessment of whether methylene blue is a suitable supportive option. Results should be interpreted with your healthcare provider.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Methylene Blue Side Effects: Clinical Evidence and Safety Considerations
Do Microdose GLP-1 Work: Evidence, Biomarkers, and Provider Selection